Article
A Novel Glucose Metabolism‐Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma
1 Jan 2021
Abstract excerpt
INTRODUCTION: Glioblastoma (GBM) is one of the most frequent primary intracranial malignancies, with limited treatment options and poor overall survival rates. Alternated glucose metabolism is a key metabolic feature of tumour cells, including GBM cells. However, due to high cellular heterogeneity, accurately predicting the prognosis of GBM patients using a single biomarker is difficult. Therefore, identifying a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
